T Cell Subsets are Associated with Clinical Activity and Efficacy of 4.5g Intravenous Glucocorticoid for Moderate-To-Severe Thyroid-Associated Ophthalmopathy

Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy

(2022) Irene Campi et al.   Frontiers in Endocrinology

Correlation between Peripheral T Cell Subsets and the Activity of Thyroid-Associated Ophthalmopathy

(2022) Hong Hu et al.   International Journal of Endocrinology

Characteristics of and reference ranges for peripheral blood lymphocytes and CD4+ T cell subsets in healthy adults in Shanxi Province, North China

(2020) Dan Xu et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Graves’ disease

(2020) Terry F. Davies et al.   Nature Reviews Disease Primers

Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids

(2020) Adriano Naselli et al.   Frontiers in Endocrinology

Current and Emerging Treatment Strategies for Graves’ Orbitopathy

(2019) Natalia Genere et al.   DRUGS

Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications

(2019) Luigi Cari et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System

(2019) Cindy Strehl et al.   Frontiers in Immunology

Immunohistochemical analysis of human orbital tissue in Graves’ orbitopathy

(2019) Y. P. Hai et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

New insights into the pathogenesis and nonsurgical management of Graves orbitopathy

(2019) Peter N. Taylor et al.   Nature Reviews Endocrinology

A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy

(2018) Yang Wang et al.   BMC Endocrine Disorders

Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy

(2018) Giovanna Rotondo Dottore et al.   JAMA Ophthalmology

The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy

(2018) Yazhuo Huang et al.   EYE

Insights into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy

(2018) Sijie Fang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Teprotumumab for Thyroid-Associated Ophthalmopathy

(2017) Terry J. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy

(2017) Wilmar M Wiersinga   Lancet Diabetes & Endocrinology

Graves’ Disease

(2016) Terry J. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Smoking was associated with poor response to intravenous steroids therapy in Graves’ ophthalmopathy

(2015) Lijing Xing et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Pathogenesis of thyroid eye disease: review and update on molecular mechanisms

(2015) Jwu Jin Khong et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy

(2015) Terry J. Smith   Nature Reviews Endocrinology

Graves' Ophthalmopathy: Epidemiology and Natural History

(2014) Yuji Hiromatsu et al.   INTERNAL MEDICINE

A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Graves' Ophthalmopathy

(2014) Wei Zhu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pathogenesis of Graves’ orbitopathy: A 2010 update

(2014) T. J. Smith   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves’ Orbitopathy: Clinical Implications

(2014) Przemyslaw Pawlowski et al.   MEDIATORS OF INFLAMMATION

Immunotherapy for Graves’ ophthalmopathy

(2014) Mario Salvi   Current Opinion in Endocrinology Diabetes and Obesity

The autoimmunity in Graves's disease 

(2013) Hong Li   Frontiers in Bioscience-Landmark

Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid disease

(2012) John H. Lazarus   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity

(2011) S. Zang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy

(2011) Andrew G Gianoukakis et al.   Current Opinion in Endocrinology Diabetes and Obesity

A Novel Thyroid Stimulating Immunoglobulin Bioassay Is a Functional Indicator of Activity and Severity of Graves’ Orbitopathy

(2010) S. D. Lytton et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Monokine Induced by Interferon γ (IFNγ) (CXCL9) and IFNγ Inducible T-Cell α-Chemoattractant (CXCL11) Involvement in Graves’ Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists

(2009) Alessandro Antonelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Graves' Ophthalmopathy

(2009) Luigi Bartalena et al.   NEW ENGLAND JOURNAL OF MEDICINE

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO

(2008) Luigi Bartalena et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY